REVIEW 6 cited by
The Brain Tumor Segmentation (BraTS-METS) Challenge 2023: Brain Metastasis Segmentation on Pre-treatment MRI
Not yet reviewed by Pith; the record is open.
This paper has not been read by Pith yet. Machine review is queued; the pith claim, tier, and objections will appear here once it completes.
SPECIMEN: schema-true, not a live event
T0 review · schema-true
One-sentence machine reading of the paper's core claim.
pith:XXXXXXXX · record.json · timestamp
Signed reviews
read the original abstract
The translation of AI-generated brain metastases (BM) segmentation into clinical practice relies heavily on diverse, high-quality annotated medical imaging datasets. The BraTS-METS 2023 challenge has gained momentum for testing and benchmarking algorithms using rigorously annotated internationally compiled real-world datasets. This study presents the results of the segmentation challenge and characterizes the challenging cases that impacted the performance of the winning algorithms. Untreated brain metastases on standard anatomic MRI sequences (T1, T2, FLAIR, T1PG) from eight contributed international datasets were annotated in stepwise method: published UNET algorithms, student, neuroradiologist, final approver neuroradiologist. Segmentations were ranked based on lesion-wise Dice and Hausdorff distance (HD95) scores. False positives (FP) and false negatives (FN) were rigorously penalized, receiving a score of 0 for Dice and a fixed penalty of 374 for HD95. Eight datasets comprising 1303 studies were annotated, with 402 studies (3076 lesions) released on Synapse as publicly available datasets to challenge competitors. Additionally, 31 studies (139 lesions) were held out for validation, and 59 studies (218 lesions) were used for testing. Segmentation accuracy was measured as rank across subjects, with the winning team achieving a LesionWise mean score of 7.9. Common errors among the leading teams included false negatives for small lesions and misregistration of masks in space.The BraTS-METS 2023 challenge successfully curated well-annotated, diverse datasets and identified common errors, facilitating the translation of BM segmentation across varied clinical environments and providing personalized volumetric reports to patients undergoing BM treatment.
Forward citations
Cited by 6 Pith papers
-
A continually expandable foundation model for brain MRI
Graph-Blueprint Pruning lets a 425,000-scan brain MRI foundation model expand across clinical domains with less forgetting than sequential tuning or EWC.
-
AI-based response assessment and prediction in longitudinal imaging for brain metastases treated with stereotactic radiosurgery
Brain metastasis trajectories cluster into five patterns, and one-year complete response can be predicted with 0.90 AUC once the 60-day follow-up scan is included.
-
Exploring Zero-Shot Anomaly Detection with CLIP in Medical Imaging: Are We There Yet?
CLIP-based zero-shot anomaly detection models achieve 3D Dice scores below 0.35 on BraTS-MET brain metastasis segmentation, indicating they are not clinically ready.
-
BraTS orchestrator : Democratizing and Disseminating state-of-the-art brain tumor image analysis
BraTS orchestrator is a new open-source package that provides uniform, tutorial-based access to winning BraTS segmentation and synthesis algorithms for brain tumor MRI.
-
MAIA: A Collaborative Medical AI Platform for Integrated Healthcare Innovation
MAIA is a modular open-source platform for collaborative medical AI development that packages Kubernetes, MONAI, and clinical imaging tools into one workspace.
-
BrainLesion Suite: A Flexible and User-Friendly Framework for Modular Brain Lesion Image Analysis
BrainLesion Suite is a modular open-source toolkit for brain lesion image analysis that combines previously published preprocessing, segmentation, and evaluation components, though the paper reports no new quantitativ...
Discussion (0). Continue with ORCID to comment.